This article explains the medical considerations for switching from semaglutide to Compounded Liraglutide with B12. Use this article if you want to understand how switching medications may affect weight loss progress, appetite, metabolism, safety, medical history, or treatment goals.
Will switching from semaglutide to Compounded Liraglutide with B12 affect my weight loss progress or metabolism?
Both semaglutide and Compounded Liraglutide with B12 belong to a group of medications called GLP-1 receptor agonists.
GLP-1 receptor agonists work in similar ways to support weight loss by:
Slowing gastric emptying
Reducing appetite
Helping you feel fuller for longer
Supporting calorie reduction
When switching from semaglutide to Compounded Liraglutide with B12, some patients may notice temporary changes while their body adjusts to the new medication.
During the transition from semaglutide to Compounded Liraglutide with B12, you may experience:
A temporary slowdown in weight loss progress
Increased hunger or cravings
A short-term weight loss plateau
Changes in appetite suppression compared to semaglutide
One of the main differences between semaglutide and Compounded Liraglutide with B12 is the dosing schedule and strength of appetite suppression.
Your prescribing clinician will help determine the safest and most appropriate transition plan based on your response to previous treatment.
Should I consult my primary care physician before switching medications?
Yes. Switching from semaglutide to Compounded Liraglutide with B12 should always happen under the supervision of a qualified healthcare professional.
Do not stop, start, or switch weight loss medications without guidance from your prescribing clinician or healthcare provider.
Your clinician may review:
Your current medication dose
Previous side effects
Existing medical conditions
Current medications
Your weight loss goals and treatment history
This clinical review helps ensure the transition from semaglutide to Compounded Liraglutide with B12 is appropriate and safe for your individual health needs.
Is Compounded Liraglutide with B12 suitable for my medical history and weight loss goals?
Compounded Liraglutide with B12 may not be appropriate for everyone.
Compounded Liraglutide with B12 is generally not recommended for people with:
A personal or family history of medullary thyroid carcinoma, also known as MTC
Multiple endocrine neoplasia syndrome type 2, also known as MEN2
Severe liver disease
Severe kidney disease
Type 1 diabetes
Pregnancy
Breastfeeding
During your consultation, Levity clinicians will review your medical history, current medications, and weight loss goals to determine whether Compounded Liraglutide with B12 is an appropriate treatment option for you.
What should I do if my medical history changes during treatment?
If something in your medical history changes while using Compounded Liraglutide with B12, notify the Levity clinical team as soon as possible.
Examples of important medical changes include:
A new diagnosis
Pregnancy
Starting new medications
Hospital admission
Significant side effects
Changes to existing medical conditions
A Levity practitioner will review the updated medical information and determine whether it is safe for you to continue Compounded Liraglutide with B12 treatment.
*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.
If you still need help after reviewing the information above, additional assistance is available.